Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Fitchett

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
European Heart Journal|November 9, 2007
Local hospital vs. core-laboratory interpretation of the admission electrocardiogram in acute coronary syndromes: increased mortality in patients with unrecognized ST-elevation myocardial infarctionRam Vijayaraghavan, Andrew T Yan, Mary Tan, et al.
The Journal of Clinical Endocrinology and Metabolism|June 3, 2020
Cardiovascular Benefit of Empagliflozin Across the Spectrum of Cardiovascular Risk Factor Control in the EMPA-REG OUTCOME TrialSilvio E Inzucchi, Kamlesh Khunti, David H Fitchett, et al.
American Heart Journal|October 18, 2008
Bleeding and outcome in acute coronary syndrome: insights from continuous electrocardiogram monitoring in the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) TrialAndrew T Yan, Raymond T Yan, Thao Huynh, et al.
European Heart Journal|June 1, 2011
Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromesDaniel J Quinlan, John W Eikelboom, Shaun G Goodman, et al.
Archives of Internal Medicine|May 30, 2007
Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromesAndrew T Yan, Raymond T Yan, Mary Tan, et al.
Archives of Internal Medicine|February 25, 2009
Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 RegistryAndrew T Yan, Raymond T Yan, Thao Huynh, et al.
The Canadian Journal of Cardiology|June 26, 2016
Secondary Prevention Beyond Hospital Discharge for Acute Coronary Syndrome: Evidence-Based RecommendationsDavid H Fitchett, Shaun G Goodman, Lawrence A Leiter, et al.
European Heart Journal|April 18, 2007
Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily betterAndrew T Yan, Raymond T Yan, Mary Tan, et al.
American Heart Journal|March 29, 2008
Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromesKi-Dong Lim, Andrew T Yan, Amparo Casanova, et al.
American Heart Journal|July 29, 2008
Impact of delayed presentation on management and outcome of non-ST-elevation acute coronary syndromesBasem Elbarouni, Shaun G Goodman, Raymond T Yan, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
European Heart Journal|November 9, 2007
Local hospital vs. core-laboratory interpretation of the admission electrocardiogram in acute coronary syndromes: increased mortality in patients with unrecognized ST-elevation myocardial infarctionRam Vijayaraghavan, Andrew T Yan, Mary Tan, et al.
The Journal of Clinical Endocrinology and Metabolism|June 3, 2020
Cardiovascular Benefit of Empagliflozin Across the Spectrum of Cardiovascular Risk Factor Control in the EMPA-REG OUTCOME TrialSilvio E Inzucchi, Kamlesh Khunti, David H Fitchett, et al.
American Heart Journal|October 18, 2008
Bleeding and outcome in acute coronary syndrome: insights from continuous electrocardiogram monitoring in the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) TrialAndrew T Yan, Raymond T Yan, Thao Huynh, et al.
European Heart Journal|June 1, 2011
Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromesDaniel J Quinlan, John W Eikelboom, Shaun G Goodman, et al.
Archives of Internal Medicine|May 30, 2007
Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromesAndrew T Yan, Raymond T Yan, Mary Tan, et al.
Archives of Internal Medicine|February 25, 2009
Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 RegistryAndrew T Yan, Raymond T Yan, Thao Huynh, et al.
The Canadian Journal of Cardiology|June 26, 2016
Secondary Prevention Beyond Hospital Discharge for Acute Coronary Syndrome: Evidence-Based RecommendationsDavid H Fitchett, Shaun G Goodman, Lawrence A Leiter, et al.
European Heart Journal|April 18, 2007
Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily betterAndrew T Yan, Raymond T Yan, Mary Tan, et al.
American Heart Journal|March 29, 2008
Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromesKi-Dong Lim, Andrew T Yan, Amparo Casanova, et al.
American Heart Journal|July 29, 2008
Impact of delayed presentation on management and outcome of non-ST-elevation acute coronary syndromesBasem Elbarouni, Shaun G Goodman, Raymond T Yan, et al.
Pageof 6